Clinical Trials · NCT05046873
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 16
- Start date
- Sep 2021
- Locations
- 1 site, Germany
- Primary endpoint
- AUC0-∞,sema,SD: Area under the semaglutide plasma concentration-time curve after a single dose